After Long Delay, Moderna Pays N.I.H. for Covid Vaccine Technique

For a chemical process that is essential to its vaccinum, Moderna has paid$ 400 million to the government. However, the parties are still embroiled in a contentious legal battle over an entirely dissimilar patent.